PainTEQ announces US launch of SI joint implant

PainTEQ has announced the commercial launch of TRAQ, an implant developed for posterior SI joint fusion, in the US. TRAQ aims to stabilise the SI joint by bi-cortical fixation and its triangular piercing barbs engage both cortices. PainTEQ CEO Shanth Thiyagalingam. Credit: PainTEQ / PRNewswire. PainTEQ has announced the commercial launch of TRAQ, an implant developed for posterior sacroiliac (SI) joint fusion, in the US. The launch brings a new option for interventionalists and surgeons, as TRAQ becomes an addition to PainTEQ’s existing portfolio alongside the LINQ system, both accessible through the same surgical approach. Combine business intelligence and editorial…

Source: Medical Device Network